Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 06/18 07:00:05 am
45.088 EUR   -1.06%
06/17FRESENIUS SEá : Deutsche Bank reiterates its Neutral rating
MD
06/10FRESENIUS SEá : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

FRESENIUS SE : Buy rating from Goldman Sachs

06/10/2021 | 08:31am EDT

Goldman Sachs is positive on the stock with a Buy rating. The target price remains unchanged at EUR 46.


ę MarketScreener with dpa-AFX Analyser 2021
All news about FRESENIUS SE & CO. KGAA
06/17FRESENIUS SEá : Deutsche Bank reiterates its Neutral rating
MD
06/10FRESENIUS SEá : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
06/09DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
06/08FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs reiterates its Buy rating
MD
06/02ANALYST RECOMMENDATIONS : Bank of America, Bodycote, Chevron, Dow Inc, Ferguson...
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies gives a Sell rating
MD
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
06/01FRESENIUS SEá : Goldman Sachs reaffirms its Buy rating
MD
05/31FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
More news
Financials
Sales 2021 36 933 M 43 994 M 43 994 M
Net income 2021 1 783 M 2 124 M 2 124 M
Net Debt 2021 22 136 M 26 369 M 26 369 M
P/E ratio 2021 14,2x
Yield 2021 1,88%
Capitalization 25 407 M 30 272 M 30 265 M
EV / Sales 2021 1,29x
EV / Sales 2022 1,18x
Nbr of Employees 310 842
Free-Float 73,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 47,60 €
Last Close Price 45,57 €
Spread / Highest target 75,6%
Spread / Average Target 4,45%
Spread / Lowest Target -61,2%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter MŘller Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA20.43%30 272
AIER EYE HOSPITAL GROUP CO., LTD.10.13%53 326
TOPCHOICE MEDICAL CORPORATION33.27%18 324
IHH HEALTHCARE3.27%12 045
BANGKOK DUSIT MEDICAL SERVICES0.00%11 525
RAMSAY HEALTH CARE LIMITED2.91%11 017